Acquiring Company
SK Biopharmaceuticals
Acquired Company
Biohaven
South Korea
United StatesBiotechnologyBiotechnologyHealth CareTherapeuticsDescription
SK Biopharmaceuticals announced its acquisition of the exclusive global rights to Opacalime, a new epilepsy drug candidate, from Biohaven. The contract, valued at up to USD 795 million, is the largest deal in the South Korean pharmaceutical sector for drug candidate introduction. This acquisition allows SK Biopharmaceuticals to strengthen its epilepsy franchise and utilize its existing U.S. sales network for potential synergies.
Don't miss SK Biopharmaceuticals's next move
Get an email the moment SK Biopharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Biohaven?
Biohaven was acquired by SK Biopharmaceuticals, based in South Korea. The deal was reported on August 29, 2026. SK Biopharmaceuticals is a biotech company focusing on the research, development, and commercialization of treatments for disorders of the central nervous system and oncology worldwide. SK Biopharmaceuticals is privately held and operates in Biotechnology.
When did SK Biopharmaceuticals acquire Biohaven?
SK Biopharmaceuticals's acquisition of Biohaven was reported on August 29, 2026. SK Biopharmaceuticals announced its acquisition of the exclusive global rights to Opacalime, a new epilepsy drug candidate, from Biohaven. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biohaven do?
Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. It is publicly traded (BHVN), operating in Biotechnology, and is based in United States.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.